Department of Infectology, Riga Stradiņš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Faculty of Residency, Riga Stradiņš University, 16 Dzirciema Street, LV-1007 Riga, Latvia.
Medicina (Kaunas). 2022 Nov 30;58(12):1760. doi: 10.3390/medicina58121760.
Respiratory diseases are one of the leading causes of death in the world, which is why a lot of attention has been recently paid to studying the possible mechanisms for the development of pulmonary diseases and assessing the impact on their course. The microbiota plays an important role in these processes and influences the functionality of the human immune system. Thus, alterations in the normal microflora contribute to a reduction in immunity and a more severe course of diseases. In this review, we summarized the information about gut and lung microbiota interactions with particular attention to their influence on the course of chronic obstructive pulmonary disease (COPD).
呼吸系统疾病是世界范围内主要的致死原因之一,因此最近人们对研究肺部疾病发展的可能机制以及评估其对疾病进程的影响给予了高度关注。微生物组在这些过程中起着重要作用,并影响着人类免疫系统的功能。因此,正常菌群的改变会导致免疫力下降,使疾病的病程更加严重。在这篇综述中,我们总结了有关肠道和肺部微生物群相互作用的信息,特别关注它们对慢性阻塞性肺疾病(COPD)病程的影响。